Improving Efficacy of Antifungal Therapy by Polymerase Chain Reaction–Based Strategy among Febrile Patients with Neutropenia and Cancer
Authors:
Open Access
- 15 November 2001
- journal article
- Published by Oxford University Press (OUP) in Clinical Infectious Diseases
- Vol. 33 (10) , 1621-1627
Abstract
Early detection of fungal infections in and corresponding early treatment of febrile patients with neutropenia and cancer have been important issuesKeywords
This publication has 29 references indexed in Scilit:
- Liposomal Amphotericin B for Empirical Therapy in Patients with Persistent Fever and NeutropeniaNew England Journal of Medicine, 1999
- Emerging fungal pathogens, drug resistance and the role of lipid formulations of amphotericin b in the treatment of fungal infections in cancer patients: A reviewInternational Journal of Infectious Diseases, 1999
- Meta-analysis of prophylactic or empirical antifungal treatment versus placebo or no treatment in patients with cancer complicated by neutropeniaBMJ, 1997
- The changing face of candidemia: emergence of non-Candida albicans species and antifungal resistanceThe American Journal of Medicine, 1996
- Fungal infections in cancer patients: An international autopsy surveyEuropean Journal of Clinical Microbiology & Infectious Diseases, 1992
- Empiric Therapy with Amphotericin B in Febrile Granulocytopenic PatientsClinical Infectious Diseases, 1991
- Amphotericin B: 30 Years of Clinical ExperienceClinical Infectious Diseases, 1990
- Fungal blood culturesEuropean Journal of Clinical Microbiology & Infectious Diseases, 1989
- Empiric antifungal therapy in febrile granulocytopenic patientsThe American Journal of Medicine, 1989
- Empiric antibiotic and antifungal therapy for cancer patients with prolonged fever and granulocytopeniaThe American Journal of Medicine, 1982